Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism

By Cusack B.   Gambliel H.   Musser B.   Hadjokas N.   Shadle S.   Charlier H.   Olson R.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 517-526

Springer Publishing Company

Access to resources Recommend Favorite

A New Conservative Approach to Extravasation of Anthracyclines with Dimethylsulfoxide and Dexrazoxane

By Bos Annelies M. E.   van der Graaf Winette T. A.   Willemse Pax H. B.  

Acta Oncologica, Vol. 40, Iss. 4, 2001-06 ,pp. : 541-542

Informa Healthcare

Access to resources Recommend Favorite

Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane

By Uges Joris W.F.   Vollaard Albert M.   Wilms Erik B.   Brouwer Rolf E.  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 467-470

Springer Publishing Company

Access to resources Recommend Favorite

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review

By Swain S.   Vici P.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 1, 2004-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel Extravasation Causing Significant Delayed Tissue Injury

By Raley J.   Geisler J.P.   Buekers T.E.   Sorosky J.I.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 259-260

Elsevier

Access to resources Recommend Favorite